126 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
the compensation of our directors;
administering our stock and equity incentive plans;
administering our compensation recovery policy;
reviewing and approving … , or making recommendations to our Board with respect to, incentive compensation and equity plans;
reviewing our overall compensation philosophy
S-8
LRMR
Larimar Therapeutics Inc
14 Mar 24
Registration of securities for employees
5:07pm
share (“Common Stock”), of Larimar Therapeutics, Inc. (the “Registrant”) issuable under the Larimar Therapeutics, Inc. 2020 Equity Incentive Plan
S-8
LRMR
Larimar Therapeutics Inc
14 Mar 24
Registration of securities for employees
5:07pm
. 2020 Equity Incentive Plan
(Full title of the plan)
Carole S. Ben-Maimon, M.D.
President and Chief Executive Officer
Larimar Therapeutics, Inc … to the shares authorized for issuance under the Larimar Therapeutics, Inc. 2020 Equity Incentive Plan (the “Plan”) as a result of the operation of an automatic
S-8
EX-5.1
LRMR
Larimar Therapeutics Inc
14 Mar 24
Registration of securities for employees
5:07pm
”), that may be issued pursuant to the Company’s 2020 Equity Incentive Plan (the “Plan”).
We have reviewed such documents and made such examination
S-8
2ip9qnyc
14 Mar 24
Registration of securities for employees
5:07pm
424B5
w4tsesa1
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
pvf2ecgok w8lqas
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.1
kiaoy16rp
17 Jul 23
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
4:08pm
424B5
no95quv xihd
14 Sep 22
Prospectus supplement for primary offering
7:28am